EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Integrated In Vitro and In Silico Characterization of 5‐Hydroxyferulic Acid: Antioxidant, Anti‐Inflammatory, Anti‐Hemolytic, and Cytotoxic Potential

Syrine Sakouhi, Sonia Ben Younes iD, Fatma Arrari, Afef Nahdi, Jalloul Bouajila, Abada Mhamdi

Chemistry & Biodiversity · 2025

DOI: 10.1002/cbdv.202501431 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemistry & Biodiversity, 2025. Verfasst von Syrine Sakouhi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Population Health, Environmental Aggressors and Alternative Therapies (LR24ES10), Faculty of Medicine of Tunis, University of Tunis-El …. Hauptthemen laut MEDLINE: Antioxidants, Coumaric Acids, Anti-Inflammatory Agents, Anti-Inflammatory Agents, Non-Steroidal. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In the pursuit of novel antioxidant and anti‐inflammatory agents, we investigated 5‐hydroxyferulic acid (5‐OHFA), a hydroxylated derivative of the well‐known phenolic compound ferulic acid (FA). This study aimed to determine whether structural modification enhances the biological activity of FA. To this end, both compounds were subjected to a series of in vitro antioxidant assays (DPPH, ABTS, FRAP, and Fe(II)‐chelating) and anti‐inflammatory evaluations, complemented by in silico predictions. 5‐OHFA consistently exhibited superior antioxidant capacity, with significantly lower IC 50 values than FA based on literature‐reported values: 11.89 ± 0.20 versus 66 ± 2.3 µM (DPPH), 9.51 ± 0.15 versus 183.08 ± 2.30 µM (ABTS), 5.94 ± 0.09 versus 4.73 ± 0.14 µM (FRAP), and 36.31 ± 1.36 versus 270.27 ± 1.14 µM (Fe 2+ chelation). It also demonstrated stronger anti‐inflammatory potential in protein denaturation assays using egg albumin and bovine serum albumin (BSA). Although 5‐OHFA showed slightly greater hemolytic activity (IC 50 = 23.78 ± 1.48 µM) than FA, based on literature‐reported values (37.64 ± 2.01 µM), both remained within biologically acceptable limits. In silico analyses using SwissADME and ProTox III supported the experimental findings, predicting good oral bioavailability, high gastrointestinal absorption, mild blood–brain barrier permeability, and no significant toxicity for 5‐OHFA. Molecular docking studies further revealed stronger binding affinities of 5‐OHFA to key oxidative and inflammatory targets, including NADPH oxidase (2CDU), xanthine oxidase (1FIQ), 5‐lipoxygenase (3O8Y), cyclooxygenase‐2 (3LN1), myeloperoxidase (1DNU), and the EGFR enzyme's active pocket (1M17). Overall, the data suggest that 5‐OHFA possesses enhanced bioactivity relative to its parent compound FA, supporting its potential as a promising multifunctional candidate for pharmaceutical or nutraceutical development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AntioxidantsCoumaric AcidsAnti-Inflammatory AgentsAnti-Inflammatory Agents, Non-SteroidalHemolysisMolecular Docking SimulationAnimalsHumansStructure-Activity RelationshipMolecular StructureCell SurvivalDose-Response Relationship, DrugMicePicratesComputer Simulation

Stichwörter der Autor:innen

5‐hydroxyferulic acidantioxidant activityanti‐cancer activityhemolytic activityinflammationmolecular docking

Substanzen

AntioxidantsCoumaric AcidsAnti-Inflammatory AgentsAnti-Inflammatory Agents, Non-SteroidalPicratesferulic acid

Autor:innen und Institutionen

  • Laboratory of Population Health, Environmental Aggressors and Alternative Therapies (LR24ES10), Faculty of Medicine of Tunis, University of Tunis-El Manar, Tunis, Tunisia.
  • Faculty of Medicine of Sousse, University of Sousse, Sousse, Tunisia.
  • Laboratory of Functional Physiology and Valorization of Bio-Resources, Higher Institute of Biotechnology of Beja, University of Jendouba, Beja, Tunisia.
  • Laboratoire de Génie Chimique, Université de Toulouse, CNRS, INP, UT, Toulouse, France.

ORCID-Profile: Sonia Ben Younes

Zitieren

APA

Sakouhi, S., Ben Younes, S., Arrari, F., Nahdi, A., Bouajila, J., & Mhamdi, A. (2025). Integrated In Vitro and In Silico Characterization of 5‐Hydroxyferulic Acid: Antioxidant, Anti‐Inflammatory, Anti‐Hemolytic, and Cytotoxic Potential. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.202501431

Vancouver

Sakouhi S, Ben Younes S, Arrari F, Nahdi A, Bouajila J, Mhamdi A. Integrated In Vitro and In Silico Characterization of 5‐Hydroxyferulic Acid: Antioxidant, Anti‐Inflammatory, Anti‐Hemolytic, and Cytotoxic Potential. Chemistry & Biodiversity. 2025. doi:10.1002/cbdv.202501431

BibTeX
@article{Sakouhi2025,
  author = {Sakouhi, Syrine and Ben Younes, Sonia and Arrari, Fatma and Nahdi, Afef and Bouajila, Jalloul and Mhamdi, Abada},
  title = {Integrated In Vitro and In Silico Characterization of 5‐Hydroxyferulic Acid: Antioxidant, Anti‐Inflammatory, Anti‐Hemolytic, and Cytotoxic Potential},
  journal = {Chemistry & Biodiversity},
  year = {2025},
  doi = {10.1002/cbdv.202501431}
}
Kostenlos starten →